| Serial Number | 79379585 |
| Word Mark | MOAI |
| Filing Date | Monday, July 3, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, October 29, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 29, 2024 |
| Description of Mark | The mark consists of the stylized wording "MOAI" within a six-sided polygon featuring a shaded triangular portion at the top and a diamond shape in the center of the letter "O" with another smaller circle within its center. |
| Goods and Services | Downloadable Computer software for data searching, tracking, exploration, processing, integration and analysis for use in the field of pharmaceuticals and molecular biology; downloadable computer software for use in the research and development of pharmaceutical preparations; downloadable computer software for use in the pharmaceutical drug development and discovery; downloadable computer software for the analysis of biological or chemical activity; downloadable computer software for the analysis of pharmaceutical properties of molecules; downloadable computer software for the identification and analysis of biological targets, networks and pathways; downloadable data processing software; downloadable computer software for creating searchable databases of information and data; downloadable computer software for data analysis, pattern discovery, contextual prediction, predictive analytics and predictive modelling; downloadable computer software for compiling and analyzing scientific, pharmaceutical and medical data; downloadable computer software for use in accessing and importing data and information; downloadable interactive databases in the fields of science, medicine and pharmaceuticals; downloadable computer software for big data analytics |
| Goods and Services | Pharmaceutical, and scientific research and development; medical research and development in the field of disease mechanisms, therapeutics and pharmaceuticals; scientific research and technological research services in the field of pharmaceuticals and molecular biology; research and development of pharmaceutical preparations and medicines; pharmaceutical drug development and discovery services; providing online non-downloadable software data searching, tracking, exploration, processing, integration and analysis for use in the field of pharmaceuticals and molecular biology; providing online non-downloadable software for data analysis, pattern discovery, contextual prediction, predictive analytics and predictive modelling; providing online non-downloadable software for the analysis of pharmaceutical properties of molecules; providing online non-downloadable software for the identification and analysis of biological targets, networks and pathways; providing online non-downloadable data processing software; providing online non-downloadable software for creating searchable databases of information and data; platform as a service (PAAS) featuring computer software platforms for data searching, tracking, exploration, processing, integration and analysis for use in the field of pharmaceuticals and molecular biology; software as a service (SAAS) services featuring software for data searching, tracking, exploration, processing, integration and analysis for use in the field of pharmaceuticals and molecular biology; data mining; providing online non-downloadable software for use in accessing, importing, compiling and analyzing scientific, pharmaceutical and medical data and information; providing online non-downloadable software for big data analytics; research and development of new products; cloud computing featuring software for data compiling, accessing, importing, searching, tracking, exploration, processing, integration, and analysis in the fields of science, medicine and pharmaceuticals; providing medical and scientific research information, advisory and consultancy services in the field of pharmaceuticals and molecular biology; providing information, advisory and consultancy services regarding research and development of pharmaceutical preparations and medicines |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 29, 2023 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 29, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Anima Biotech Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | US |
| Party Name | Anima Biotech Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | US |
| Event Date | Event Description |
| Thursday, September 28, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, September 29, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 3, 2023 | APPLICATION FILING RECEIPT MAILED |
| Friday, March 15, 2024 | ASSIGNED TO EXAMINER |
| Monday, March 25, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 26, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, April 12, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, April 12, 2024 | REFUSAL PROCESSED BY MPU |
| Wednesday, May 8, 2024 | REFUSAL PROCESSED BY IB |
| Friday, September 13, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, September 13, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, September 14, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 19, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, September 19, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, September 19, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, September 19, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, September 19, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, October 9, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 29, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 29, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, November 6, 2024 | TEAS POST PUBLICATION AMENDMENT RECEIVED |